Market capitalization | $143.30m |
Enterprise Value | $163.11m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 32.43 |
EV/Sales (TTM) EV/Sales | 1.77 |
P/S ratio (TTM) P/S ratio | 1.56 |
P/B ratio (TTM) P/B ratio | 1.22 |
Revenue growth (TTM) Revenue growth | 28.81% |
Revenue (TTM) Revenue | $92.13m |
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
7 Analysts have issued a OptimizeRx Corporation forecast:
7 Analysts have issued a OptimizeRx Corporation forecast:
Dec '24 |
+/-
%
|
||
Revenue | 92 92 |
29%
29%
|
|
Gross Profit | 55 55 |
36%
36%
|
|
EBITDA | -1.89 -1.89 |
83%
83%
|
EBIT (Operating Income) EBIT | -6.22 -6.22 |
53%
53%
|
Net Profit | -20 -20 |
14%
14%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
Head office | United States |
CEO | Stephen Silvestro |
Employees | 129 |
Founded | 1985 |
Website | www.optimizerx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.